| Primary |
| Cancer Pain |
25.2% |
| Product Used For Unknown Indication |
24.0% |
| Pain |
21.2% |
| Drug Use For Unknown Indication |
6.8% |
| Ill-defined Disorder |
3.9% |
| Analgesic Therapy |
3.8% |
| Prophylaxis |
2.7% |
| Constipation |
1.8% |
| Back Pain |
1.5% |
| Insomnia |
1.4% |
| Rheumatoid Arthritis |
1.3% |
| Osteoarthritis |
1.0% |
| Spinal Column Stenosis |
1.0% |
| Delirium |
0.9% |
| Hypertension |
0.8% |
| Depression |
0.7% |
| Pneumonia Aspiration |
0.5% |
| Hepatic Cirrhosis |
0.5% |
| Musculoskeletal Pain |
0.5% |
| Periarthritis |
0.5% |
|
| Wrong Technique In Drug Usage Process |
37.9% |
| Drug Prescribing Error |
28.2% |
| Inappropriate Schedule Of Drug Administration |
6.5% |
| Somnolence |
4.8% |
| Treatment Noncompliance |
2.7% |
| Incorrect Drug Administration Duration |
2.5% |
| Vomiting |
2.5% |
| Delirium |
2.3% |
| Nausea |
2.2% |
| Death |
1.7% |
| Pain |
1.2% |
| Respiratory Depression |
1.2% |
| Inadequate Analgesia |
1.0% |
| Restlessness |
0.9% |
| Off Label Use |
0.8% |
| Withdrawal Syndrome |
0.8% |
| Disease Progression |
0.7% |
| Expired Drug Administered |
0.7% |
| Malignant Neoplasm Progression |
0.7% |
| Constipation |
0.6% |
|
| Secondary |
| Pain |
25.7% |
| Cancer Pain |
16.5% |
| Analgesic Therapy |
11.0% |
| Product Used For Unknown Indication |
7.1% |
| Delirium |
5.2% |
| Prophylaxis |
4.3% |
| Insomnia |
4.1% |
| Constipation |
3.6% |
| Pneumonia Aspiration |
3.6% |
| Rheumatoid Arthritis |
2.9% |
| Lumbar Vertebral Fracture |
2.7% |
| Trigeminal Neuralgia |
2.7% |
| Spinal Column Stenosis |
2.0% |
| Drug Use For Unknown Indication |
1.8% |
| Back Pain |
1.3% |
| Musculoskeletal Pain |
1.3% |
| Periarthritis |
1.2% |
| Hyponatraemia |
1.2% |
| Lumbar Spinal Stenosis |
1.0% |
| Hepatic Cirrhosis |
0.8% |
|
| Wrong Technique In Drug Usage Process |
37.2% |
| Somnolence |
14.3% |
| Vomiting |
8.3% |
| Drug Prescribing Error |
5.2% |
| Nausea |
4.3% |
| Treatment Noncompliance |
3.8% |
| Suicide Attempt |
2.7% |
| Loss Of Consciousness |
2.5% |
| Pain |
2.5% |
| Gastric Cancer |
2.3% |
| Constipation |
2.2% |
| Restlessness |
2.2% |
| Rectal Perforation |
2.0% |
| Platelet Count Decreased |
1.6% |
| Rash |
1.6% |
| Delirium |
1.4% |
| Inadequate Analgesia |
1.4% |
| Inappropriate Schedule Of Drug Administration |
1.4% |
| Off Label Use |
1.4% |
| Product Quality Issue |
1.4% |
|
| Concomitant |
| Prophylaxis |
19.1% |
| Cancer Pain |
12.6% |
| Colorectal Cancer |
12.1% |
| Product Used For Unknown Indication |
7.5% |
| Hypertension |
6.5% |
| Multiple Myeloma |
6.0% |
| Pain |
5.5% |
| Gastritis |
4.5% |
| Sepsis |
4.0% |
| Anaemia |
2.0% |
| Conjunctivitis |
2.0% |
| Constipation |
2.0% |
| Drug Use For Unknown Indication |
2.0% |
| Ileus |
2.0% |
| Ileus Paralytic |
2.0% |
| Nausea |
2.0% |
| Ovarian Cancer |
2.0% |
| Ovarian Cancer Recurrent |
2.0% |
| Stomatitis |
2.0% |
| Uterine Cancer |
2.0% |
|
| Pneumonia |
10.0% |
| Dermatitis Acneiform |
6.7% |
| Infusion Related Reaction |
6.7% |
| Rash |
6.7% |
| Renal Function Test Abnormal |
6.7% |
| Stomatitis |
6.7% |
| Tetany |
6.7% |
| Thrombocytopenia |
6.7% |
| White Blood Cell Count Decreased |
6.7% |
| Convulsion |
3.3% |
| Diarrhoea |
3.3% |
| Disease Progression |
3.3% |
| Drug Withdrawal Convulsions |
3.3% |
| Female Genital Tract Fistula |
3.3% |
| Hypocalcaemia |
3.3% |
| Hypomagnesaemia |
3.3% |
| Ileus Paralytic |
3.3% |
| Off Label Use |
3.3% |
| Ovarian Cancer |
3.3% |
| Ovarian Cancer Recurrent |
3.3% |
|
